Latest Accounting News

The ASX has published its latest list of entities suspended from trading for over three months, outlining key deadlines for report lodgement and trading resumption plans. Failure to meet these deadlines risks removal from the official list.

ImpediMed has doubled its US unit sales in Q4 FY25, achieving a record total contract value and securing an additional $5 million tranche under its growth capital facility.

Phoslock Environmental Technologies reported a $474,000 cashflow deficit in Q2 2025, with sales impacted by deferred European projects and ongoing US tariff uncertainties. Factory refurbishment delays push production restart to early 2026.

Legend Mining Limited reported a stable cash flow for the June 2025 quarter, ending with nearly AUD 11.8 million in cash and equivalents and an estimated 32.7 quarters of funding available.

oOh!media has confirmed that its contract with Auckland Transport, accounting for 4% of FY24 revenue, will not be renewed after September 2025. Despite this setback, the company remains confident in its New Zealand market position.

Ava Risk Group reports a positive EBITDA turnaround for FY2025 despite missing revenue guidance due to delayed key orders. The company highlights strong momentum in telecommunications and aviation sectors with promising technology deployments.

HUB24 Limited has reported a record $19.8 billion in net inflows for FY25, driven by strong platform growth and significant migrations from Equity Trustees. The company also launched an innovative high net worth solution, reinforcing its market leadership.

Trigg Minerals has defined a substantial Exploration Target at its Antimony Canyon Project in Utah, estimating up to 15.6 million tonnes of ore with significant antimony content. The company plans advanced exploration to convert this target into a formal resource.

MyEco Group Ltd reported an 8.6% rise in FY25 sales driven by strong growth in its global MyEco® product line and new UK retail partnerships, while navigating challenges in resin markets and US tariffs.

South32 warns of an impending impairment expense linked to uncertain electricity supply for its Mozal Aluminium smelter, with FY26 production guidance now under review amid ongoing tariff negotiations.

Pacific Edge reports steady demand for its Cxbladder cancer diagnostic tests despite losing Medicare coverage and transitioning US customers to a new test. The company is advancing clinical evidence and a $21 million capital raise to support growth and regain coverage.

Queste Communications reported a significant $3 million cash inflow in June 2025, driven by a royalty termination payment from its controlled entity, Orion Equities Limited, strengthening its liquidity position.